Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2280]
News [5237]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
A potential prognostic biomarker of chemoresistance in mCRC treated with FUFIRI...
Dr Arndt Stahler - University of Munich, Munich, Germany
A potential prognostic biomarker of chemoresistance in mCRC treated with FUFIRI or mIrOx (FIRE1) ( Dr Arndt Stahler - University of Munich, Munich, Germany )
9 Oct 2016
Phase I results of a novel FGFR inhibitor
Dr Markus Joerger - Kantonsspital St. Gallen, St. Gallen, Switzerland
Phase I results of a novel FGFR inhibitor ( Dr Markus Joerger - Kantonsspital St. Gallen, St. Gallen, Switzerland )
9 Oct 2016
Adjuvant cetuximab in the PETACC8 trial for stage III colon cancer
Prof Julien Taïeb - Georges Pompidou European Hospital, Paris, France
Adjuvant cetuximab in the PETACC8 trial for stage III colon cancer ( Prof Julien Taïeb - Georges Pompidou European Hospital, Paris, France )
8 Oct 2016
Combining drugs with radiotherapy
Prof John Staffurth - Cardiff University, Cardiff, UK
Combining drugs with radiotherapy ( Prof John Staffurth - Cardiff University, Cardiff, UK )
5 Oct 2016
A novel biomarker for paediatic tumours
Dr Kathleen Birley - UCL Institute of Child Health, London, UK
A novel biomarker for paediatic tumours ( Dr Kathleen Birley - UCL Institute of Child Health, London, UK )
5 Oct 2016
ALK mutations in paediatric tumours
Dr Suzanne Turner - Cambridge University, Cambridge, UK
ALK mutations in paediatric tumours ( Dr Suzanne Turner - Cambridge University, Cambridge, UK )
5 Oct 2016
When is an assay ready for the clinic?
Dr Erasmus Schneider - Wadsworth Center, Albany, USA
When is an assay ready for the clinic? ( Dr Erasmus Schneider - Wadsworth Center, Albany, USA )
28 Sep 2016
Innovative imaging techinques to visualise drug targets
Prof Guus van Dongen - VU University Medical Center, Amsterdam, Netherlands
Innovative imaging techinques to visualise drug targets ( Prof Guus van Dongen - VU University Medical Center, Amsterdam, Netherlands )
26 Sep 2016
Design and value of immunohistochemical assays
Dr Stephen Hewitt - National Institutes of Health, Bethesda, USA
Design and value of immunohistochemical assays ( Dr Stephen Hewitt - National Institutes of Health, Bethesda, USA )
26 Sep 2016
What is the role of surgery in melanoma treatment?
Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy
What is the role of surgery in melanoma treatment? ( Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy )
26 Sep 2016
Making sense of genetic associations with childhood leukaemia risk
Prof Mehmet Dorak - Liverpool Hope University, Liverpool, UK
Making sense of genetic associations with childhood leukaemia risk ( Prof Mehmet Dorak - Liverpool Hope University, Liverpool, UK )
26 Sep 2016
The timeline of adjuvant and neoadjuvant therapy for melanoma
Dr Jean Jacques Grob - Hôpital de la Timone, Marseille, France
The timeline of adjuvant and neoadjuvant therapy for melanoma ( Dr Jean Jacques Grob - Hôpital de la Timone, Marseille, France )
23 Sep 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation